FDA clears Abbott high sensitivity troponin-I test

Create PDF

December 2019—Abbott announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from the FDA for use on the Architect analyzer.

The test measures very low levels of troponin, allowing clinicians to evaluate heart attack in patients within two to four hours of admission.